Abstract
Malignant rhabdoid tumor of the kidney (MRTK) is one of the most lethal neoplasms to occur in young infants. Cases of MRTK accompanying an embryonal tumor in the central nervous system have occasionally been described. We present herein an interesting case of MRTK that was clinically diagnosed preoperatively. A male infant aged 6 months with both a midline brain tumor and a renal neoplasm was transferred to our institution. Although roentgenographic evaluation suggested that the renal lesion was a Wilms’ tumor, midkine (MK), a growth and differentiation factor characteristically present in the urine of patients with Wilms’ tumor, was not detected. A preoperative diagnosis of MRTK was established based on the lack of urinary MK in addition to the typical clinical features of the young age and the concurrent brain tumor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
D’Angio GJ, Breslow N, Beckwith JB, Evans A, Baum E, deLorimier A, Fernbach D, Hrabovsky E, Jones B, Kelalis P, Othersen B, Tefft M, Thomas PRM (1989) Treatment of Wilms’ tumor: results of the Third National Wilms’ Tumor Study. Cancer 64:349–360
Marsden HB, Lawler W, Kumar PM (1978) Bone metastasizing renal tumor of childhood: morphological and clinical features, and differences from Wilms’ tumor. Cancer 42:1922–1928
Palmer NF, Sutow W (1983) Clinical aspects of the rhabdoid tumor of the kidney: a report of the National Wilms’ Tumor Study Group. Med Pediatr Oncol 11:242–245
Muramatsu T (1993) Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int J Dev Biol 37:183–188
Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF, Knott TJ (1985) Insulin-like growth factor-II gene expression in Wilms’ tumour and embryonic tissues. Nature 317:260–262
Fraizer GE, Bowen-Pope DF, Vogel AM (1987) Production of platelet-derived growth factor by cultured Wilms’ tumor cells and fetal kidney cells. J Cell Physiol 133:169–174
Bonnin JM, Rubinstein LJ, Palmer NF, Beckwith JB (1984) The association of embryonal tumors originating in the kidney and in the brain. Cancer 54:2137–2146
Dehner LP (1986) Peripheral and central primitive neuroectodermal tumors; a nosologic concept seeking a consensus. Arch Pathol Lab Med 110:997–1005
Ota S, Crabbe DCG, Tran TN, Triche TJ, Shimada H (1993) Malignant rhabdoid tumor. A study with two established cell lines. Cancer 71:2862–2872
Tsutsui J, Kadomatsu K, Matsubara S, Nakagawara A, Hamanoue M, Takao S, Shimazu H, Ohi Y, Muramatsu T (1993) A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms’ tumor and other human carcinomas. Cancer Res 53:1281–1285
Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III (1992) Repression of the insulinlike growth factor II gene by the Wilms tumor suppressor WT1. Science 257:674–678
Adachi Y, Matsubara S, Pedraza C, Ozawa M, Tsutsui J, Takamatsu H, Noguchi H, Akiyama T, Muramatsu T (1996) Midkine as a novel target gene for the Wilms’ tumor suppressor gene (WT1). Oncogene 13:2197–2203
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adachi, Y., Takamatsu, H., Noguchi, H. et al. A malignant rhabdoid tumor of the kidney occcurring concurrently with a brain tumor: Report of a case. Surg Today 30, 298–301 (2000). https://doi.org/10.1007/s005950050064
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s005950050064